Cargando…
Cross-talk of inflammatory mediators and airway epithelium reveals the cystic fibrosis transmembrane conductance regulator as a major target
Airway inflammation, mucus hyperproduction and epithelial remodelling are hallmarks of many chronic airway diseases, including asthma, COPD and cystic fibrosis. While several cytokines are dysregulated in these diseases, most studies focus on the response of airways to interleukin (IL)-4 and IL-13,...
Autores principales: | Simões, Filipa B., Kmit, Arthur, Amaral, Margarida D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666577/ https://www.ncbi.nlm.nih.gov/pubmed/34912883 http://dx.doi.org/10.1183/23120541.00247-2021 |
Ejemplares similares
-
Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia
Publicado: (1992) -
Cystic fibrosis transmembrane conductance regulator in COPD: a role in respiratory epithelium and beyond
por: Mall, Marcus A., et al.
Publicado: (2023) -
Resveratrol Enhances Airway Surface Liquid Depth in Sinonasal Epithelium by Increasing Cystic Fibrosis Transmembrane Conductance Regulator Open Probability
por: Zhang, Shaoyan, et al.
Publicado: (2013) -
Correction: Resveratrol Enhances Airway Surface Liquid Depth in Sinonasal Epithelium by Increasing Cystic Fibrosis Transmembrane Conductance Regulator Open Probability
por: Zhang, Shaoyan, et al.
Publicado: (2014) -
Lack of cystic fibrosis transmembrane conductance regulator disrupts fetal airway development in pigs
por: Meyerholz, David K., et al.
Publicado: (2018)